Embodiments of the invention are directed towards a medical device, method and system thereof for the placement or passage of patches, sutures, anchors, tags, tissue sensors and more particularly to a medical device for repairing female pelvic organ or tissue prolapsed region. The device may be used for the placement of stereotactic markers into tissue near joints or tumors for guidance during orthopedic or neurosurgical procedures.

According to an aspect, a medical device includes an elongate member, a needle, and a suture. The needle is movably coupled to the elongate member. The suture is disposed within a lumen defined by the elongate member. The suture has a coupling member coupled to a first portion of the suture. The coupling member is configured to be coupled to a second portion of the suture.

The present invention relates to biologic tissues, which are used to create cellular matrix scaffolds to help repair the body. The invention discloses two specific implant shapes that are pre-cut to address two separate pelvic floor prolapses (anterior and/or posterior). Additionally, the method of providing surgeries-specific pre-shaped biologic scaffolds is also claimed.

Extra-urethral implants and methods of use are disclosed. Implants can treat disorders or diseases of the prostate by, for example, enlarging the lumen of the prostatic urethra.

An intravaginal device that has a hollow open-ended cylindrical body and a removal strip, wherein the body has features that keep the removal strip in a track. During removal when the removal strip is pulled, the cross-sectional area of the device is decreased. A kit includes the device, removal strip and an assistive wand to aid with insertion and removal.

One or more sensors are incorporated onto one or more of an implantable device and a surgical tool used for placement and/or adjustment of the implantable device. The implantable device includes an adjustable membrane element for controllable coaptation of a body lumen, such as coaptation of a urethra as treatment for urinary incontinence. In various embodiments, the one or more sensors can be configured to detect information indicative of at least one of a shape of the adjustable membrane element, a position of the adjustable membrane element relative to the body lumen, or a shape of the body lumen.

The invention relates to an accessory for implanting a medical device in a human or animal body, said medical device comprising an occlusion collar (1) adapted to surround and to seal an anatomical duct of said human or animal body, a fluid reservoir (2) and a tube (3) connecting the reservoir to the occlusion collar, said accessory comprising:—a plug (100; 100) adapted to seal an end of the tube; and—a collar (200) adapted to surround the tube, the plug (100) and the collar (200) having respective connection portions (103, 104; 203, 204) adapted to engage so as to fix the collar (200) and the plug (100) together so as to hermetically seal said end of the tube (3).

One or more sensors are incorporated onto one or more of an implantable device and a surgical tool used for placement and/or adjustment of the implantable device. The implantable device includes an adjustable membrane element for controllable coaptation of a body lumen, such as coaptation of a urethra as treatment for urinary incontinence. In various embodiments, the one or more sensors can be configured to detect information indicative of at least one of a shape of the adjustable membrane element, a position of the adjustable membrane element relative to the body lumen, or a shape of the body lumen.

A system and associated method for altering or destroying tissues and anatomical or other structures in medical applications for the purpose of treating diseases or disorders. In one aspect, the system includes a device configured to deploy devices for altering the lobes of a prostate.

The present invention relates to an in-vivo bulking agent which can be used as a medicinal agent for prevention or treatment of at least one disease selected from the group consisting of urinary incontinence, fecal incontinence, and gastroesophageal reflux or as a filler for use in a plastic surgery procedure, and to a preparation method therefor. The in-vivo bulking agent can exhibit a bulking effect when injected into the body and particularly, is highly biocompatible because a first composition in which silicone particles are coated with a zwitterionic polymer having a surfactant property is introduced into a second composition, whereby the bulking agent can inhibit inflammatory reactions in vivo.